Stay updated with breaking news from Terrence Norchi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FRAMINGHAM, Mass., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today
Common Stock Listing on National Exchange is Next Planned Significant Milestone...
Image Courtesy | Arch Therapeutics Abrams joined the company on Monday ahead of taking over the CFO role on Monday, May 10, according to a release from Arch. He will replace current CFO Richard Davis, who will remain with the company during a transition period to end on June 30 although he will continue on in a consulting role through the end of the year. Abrams has more than 25 years of experience as a CFO to numerous public and private companies, according to Arch. He has also served as a principal investor; investment banker; merchant banker; strategic and financial advisor; and board memb...